Ellerston Capital Investor
Ellerston Capital specialises in equity strategies. Today, they have over $5.1 billion in funds under management (as at 28 February 2017) – including separately managed accounts (SMAs), wholesale funds and retail offerings for a range of financial advisers, institutions and individual investors.
As a dedicated investment manager, they aim to do one thing exceptionally well: grow and protect their clients’ wealth through investing. They are passionate about creating value for their clients by identifying outstanding stocks and designing portfolios that perform over the long term.
Investor Type:
Hedge Funds
Technology:
Biomarker Discovery & Validation
Founded Date:
1999-01-01
Industry:
BioPharma AI
Employee Number:
101-250
Funding Status:
private
Number Of Exists:
6
Headquarters:
Sydney,New South Wales,Australia,Oceania

